ClearPoint Neuro
CLPT
118 hedge funds and large institutions have $155M invested in ClearPoint Neuro in 2025 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 31 increasing their positions, 34 reducing their positions, and 14 closing their positions.
86% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 14
83% more call options, than puts
Call options by funds: $7.35M | Put options by funds: $4.02M
10% more funds holding
Funds holding: 107 → 118 (+11)
4.75% more ownership
Funds ownership: 35.08% → 39.83% (+4.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 34
30% less capital invested
Capital invested by funds: $223M → $155M (-$67.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Stempoint Capital
New York
|
+$8.62M |
| 2 |
Millennium Management
New York
|
+$6.07M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.99M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$4.03M |
| 5 |
Goldman Sachs
New York
|
+$3.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Focus Partners Wealth
Boston,
Massachusetts
|
-$8.13M |
| 2 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
-$6.19M |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$5.07M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$4.56M |
| 5 |
Morgan Stanley
New York
|
-$2.27M |
CLPT Hedge Fund Activity: Q4 2025 in Review
118 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q4 2025, worth a combined $155M — down 30% from $223M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new CLPT positions and 14 closed out — a net gain of 12 holders — while 31 added to existing stakes and 34 trimmed.
The largest buyer was Stempoint Capital, adding an estimated $8.62M. The largest seller was Focus Partners Wealth, exiting entirely with an estimated $8.13M sold.
- 118 institutional investors held ClearPoint Neuro (CLPT) as of Q4 2025, up from 107 in Q3 2025.
- Funds reported $155M of ClearPoint Neuro stock for Q4 2025, down 30% quarter-over-quarter.
- 26 funds opened new ClearPoint Neuro positions in Q4 2025 and 14 closed out, a net change of +12 holders.
- The largest ClearPoint Neuro buyer in Q4 2025 was Stempoint Capital, an estimated $8.62M added.
- The largest ClearPoint Neuro seller in Q4 2025 was Focus Partners Wealth, an estimated $8.13M sold.
Based on aggregated 13F filings for Q4 2025.